Hyloris Developments
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction (NCT06143787) | Hyloris Developments | 2023-11-07 |
Track Hyloris Developments automatically
Every clearance here is in the API, with alerts when new ones post.